PHARMA
Pharmaceutical IT Asia Congress To Highlight Digital Healthcare Innovation
Oxford Global’s Pharmaceutical IT Asia Congress will take place from March 25-26, 2014 in Singapore..
Quintiles, Vietnam Ministry Of Health To Collaborate
The Vietnam Ministry of Health has signed an agreement with Quintiles to enhance clinical research in Vietnam’s growing nation of 90 million people.
Mode Of Action Of Plerixafor Unraveled
Scientists have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia.
A*STAR, AstraZeneca To Develop Gram-Negative Antibacterials
A*STAR has signed an agreement with biopharmaceutical company AstraZeneca to develop new drugs to treat gram-negative bacterial infections.
Eisai, Broad Institute Develop Treatment For NTDs And Tuberculosis
Eisai Co., Ltd. has entered into an agreement with the Broad Institute to develop new therapeutic agents for the treatment of neglected tropical diseases and tuberculosis.
Bangladesh’s Battle With Fake And Low-Standard Medicine
The Bangladeshi government has vowed to continue fighting the growing industry of illicit, substandard, counterfeit and life-endangering medicines openly sold in pharmacies.
AB SCIEX Opens R&D Center In Singapore
AB SCIEX has announced the opening of a new research and development center in Singapore.
Bristol-Myers Squibb, Kyowa Hakko Kirin To Commercialize Coniel In China
Bristol-Myers Squibb and Kyowa Hakko Kirin will commercialize Coniel, a calcium channel blocker for the treatment of hypertension and angina pectoris, in China.
3SBio To Develop DJ5 For Progressive Renal Failure
3SBio Inc. has acquired patents for DJ5 to develop DJ5 as a treatment for progressive renal failure in patients with autosomal dominant polycystic kidney disease.
